-
Maternal thyroid function at 11-13 weeks of gestation.
Ashoor G, Kametas NA, Akolekar R, Guisado J, Nicolaides KH.
Fetal Diagn Ther 2010;27:156-63. -
Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death.
Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH.
Thyroid 2010;20:989-93. -
Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation.
Akolekar R, Farkas DH, Vanagtmael AL, Bombard AT, Nicolaides KH.
Prenat Diagn 2010;30:918-23. -
Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
Akolekar R, Cruz JJ, Foidart JM, Munaut C, Nicolaides KH.
Prenat Diagn 2010;30:191-7. -
Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R, Pérez Penco JM, Skyfta E, Rodríguez Calvo J, Nicolaides KH.
Fetal Diagn Ther 2010;27:72-7. -
Development of a training model for ultrasound-guided invasive procedures in fetal medicine.
Ville Y, Cooper M, Revel A, Frydman R, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:180-3. -
Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome.
Ville Y, Hyett J, Hecher K, Nicolaides KH.
N Engl J Med 1995;332:224-7. -
Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancy.
Tsakonas DP, Nicolaides KH, Tsakona CP, Worman CP, Goldstone AH.
Clin Lab Haematol 1995;17:57-9. -
Neutrophil and monocyte beta 2-integrin expression in maternal and fetal blood.
Thilaganathan B, Makrydimas G, Plachouras N, Nicolaides KH.
Am J Obstet Gynecol 1995;172:58-62. -
Maternal platelet size as a marker for fetal trisomies 18 and 13.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:605-8. -
Blood transferrin receptor expression in chromosomally abnormal fetuses.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:282-4. -
Fetal oxygenation at cordocentesis, maternal smoking and childhood neuro-development.
Soothill PW, Ajayi RA, Campbell S, Ross EM, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 1995;59:21-4. -
Prevalence of fetal facial cleft at different stages of pregnancy.
Snijders RJ, Sebire NJ, Psara N, Souka A, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:327-9. -
Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.
Snijders RJ, Sebire NJ, Souka A, Santiago C, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:250-5. -
Fetal exomphalos at 11 to 14 weeks of gestation.
Snijders RJ, Brizot ML, Faria M, Nicolaides KH.
J Ultrasound Med 1995;14:569-74. -
Maternal age and gestational age-specific risk for chromosomal defects.
Snijders RJ, Sebire NJ, Nicolaides KH.
Fetal Diagn Ther 1995;10:356-67. -
Fetal mild hydronephrosis and chromosomal defects: relation to maternal age and gestation.
Snijders RJ, Sebire NJ, Faria M, Patel F, Nicolaides KH.
Fetal Diagn Ther 1995;10:349-55. -
Effect of delivery on fetal erythropoietin and blood gases in pregnancies with maternal diabetes mellitus.
Salvesen DR, Brudenell MJ, Nicolaides KH.
Fetal Diagn Ther 1995;10:141-6. -
First trimester fetal nuchal translucency.
Pandya PP, Santiago C, Snijders RJ, Nicolaides KH.
Curr Opin Obstet Gynecol 1995;7:95-102. -
Natural history of trisomy 21 Fetuses with fetal nuchal translucency.
Pandya PP, Snijders RJM, Johnson S, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:381-3.